Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis

2005 ◽  
Vol 43 (2) ◽  
pp. 358-360 ◽  
Author(s):  
Johan Fevery ◽  
Otto Buchel ◽  
Frederik Nevens ◽  
Chris Verslype ◽  
Sigrid Stroobants ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Early Diagnosis ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Reliable Method ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography

Hepatology ◽  
1998 ◽  
Vol 28 (3) ◽  
pp. 700-706 ◽  
Author(s):  
Susanne Keiding ◽  
S�ren B. Hansen ◽  
Henrik H Rasmussen ◽  
Antony Gee ◽  
Aksel Kruse ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography

Hepatology ◽  
1999 ◽  
Vol 29 (2) ◽  
pp. 611-613 ◽  
Author(s):  
Frieder Berr ◽  
Marcus Wiedmann ◽  
Joachim Mössner ◽  
Andrea Tannapfel ◽  
Frank Schmidt
Keyword(s):  
Positron Emission Tomography ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Emission Tomography ◽  
Positron Emission

18F-FDG positron emission tomography in the early diagnosis of enterocolitis: preliminary results

2002 ◽  
Vol 29 (10) ◽  
pp. 1389-1392 ◽  
Author(s):  
E. Kresnik ◽  
H. Gallowitsch ◽  
P. Mikosch ◽  
F. Würtz ◽  
D. Alberer ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Early Diagnosis ◽  
Emission Tomography ◽  
Preliminary Results ◽  
Positron Emission ◽  
18F Fdg

Arguments against the biomarker-driven diagnosis of AD

2012 ◽  
Vol 25 (2) ◽  
pp. 177-181 ◽  
Author(s):  
Helen F.K. Chiu ◽  
Henry Brodaty
Keyword(s):  
Magnetic Resonance Imaging ◽  
Positron Emission Tomography ◽  
Cerebrospinal Fluid ◽  
Magnetic Resonance ◽  
Early Diagnosis ◽  
Research Agenda ◽  
Emission Tomography ◽  
Resonance Imaging ◽  
Positron Emission ◽  
Magnetic Resonance Imaging Mri

Impressive developments in the biomarker diagnosis of Alzheimer's disease (AD and pre-symptomatic states, using cerebrospinal fluid (CSF), positron emission tomography (PET), magnetic resonance imaging (MRI), and proteomics, have been at the forefront of research in the last decade. With the publication of the criteria of Dubois et al. (2007) and the revised National Institute on Aging and Alzheimer's Association (NIA–AA) criteria for the diagnosis of AD (Jack et al., 2011), this has further ignited the interest and enthusiasm for researchers and clinicians in the field. In some of the major conferences on dementia in recent years, the topic of the biomarker-driven diagnosis of AD has dominated the research agenda. But many questions arise as to how this research will translate into practice. Here, we would like to put forward our arguments against a biomarker-driven diagnosis of AD, and we would caution that very early diagnosis of AD may not result in better care of the subjects.

Sign in / Sign up

Export Citation Format

Share Document